Archiving Chain of Custody Records in Clinical Trials: Regulatory Strategies and Best Practices

Introduction: Why Archiving CoC Records Matters

Chain of Custody (CoC) records ensure accountability in the handling, transfer, and receipt of clinical samples throughout the trial lifecycle. These records serve as crucial evidence of sample integrity and regulatory compliance. Improper or incomplete archiving of these documents can jeopardize trial outcomes, lead to inspection findings, or even data rejection.

With FDA, EMA, and ICH-GCP increasingly focused on data integrity and traceability, the need for robust CoC record archiving systems has never been greater. This article provides a comprehensive guide on archiving CoC documentation — from regulatory expectations and retention timelines to real-world examples, digitization strategies, and CAPA considerations.

Regulatory Expectations for Chain of Custody Document Archiving

CoC logs, whether in paper or electronic format, must be archived in compliance with the following regulatory standards:

• FDA 21 CFR 312.57(c): Sponsors must retain records, including custody logs, for at least 2 years after the last approval or discontinuation.
• EMA GCP Directive 2005/28/EC: Requires retention of essential trial documents (including sample transfer logs) for at least 5 years post-trial or longer depending on national law.
• ICH GCP E6(R2): Emphasizes that documentation must be stored in a manner that ensures accessibility, legibility, and audit-readiness.

CoC records are part of the essential documents listed in ICH GCP and must be included in the Trial Master File (TMF) or equivalent systems. Their preservation is central to demonstrating compliance during audits and inspections.

Types of Chain of Custody Records That Require Archiving

• Site-generated custody logs (paper or electronic)
• Courier handover documentation
• Lab intake records (e-signature or stamped)
• Temperature tracking during shipment
• Deviation or discrepancy reports related to sample transfer
• Corrective and Preventive Action (CAPA) records associated with custody issues
• Training records for CoC SOPs

Paper vs. Electronic: Choosing the Right Archiving Format

The choice between paper and electronic storage depends on the sponsor’s archiving infrastructure, system validation, and regulatory acceptance in operational regions. Here’s a comparison:

Case Study: CAPA Triggered by Inaccessible Archived CoC Logs

During a sponsor inspection in Germany, EMA inspectors requested access to archived custody records for a study completed 6 years earlier. The CRO responsible for archiving had moved the boxes offsite and mislabeled the storage location. It took over 3 weeks to retrieve the records.

Findings: Lack of inventory tracking system and archiving SOP deficiencies.

CAPA Measures:

• Established a centralized document inventory system with barcode tracking
• Updated archiving SOP to include detailed indexing and access protocol
• Trained CRO staff on archiving procedures and sponsor access requirements

Best Practices for CoC Archiving

• Create an SOP for archiving chain of custody records specific to GCP requirements
• Maintain an up-to-date archive inventory log including box number, content, and retrieval pathway
• Ensure backup of electronic custody logs in multiple data centers (if cloud-based)
• Include CoC records in TMF/eTMF system with clear labeling
• Audit archive vendors annually and document qualification/agreements
• Ensure that scanned copies of paper custody logs are certified as true copies
• Track chain of custody record lifecycle from creation to destruction/retirement

Retention Timelines by Region

External Reference for Archiving Guidance

For broader expectations on retention and digital preservation of clinical records, refer to Japan’s RCT Portal which includes PMDA-linked documentation requirements.

Conclusion

Archiving chain of custody records is not just a storage task—it is a regulatory obligation. Whether through eTMF systems, physical archives, or hybrid models, clinical teams must implement traceable, audit-ready, and SOP-driven practices. By aligning with global retention timelines and inspection readiness strategies, sponsors can ensure the long-term integrity and usability of their sample custody records, even years after trial closure.

Essential Templates for Clinical Trial Training Logs and Attendance Sheets

Introduction: Why Templates Matter in Clinical Training Documentation

In clinical research, training documentation is a regulatory requirement—not just a formality. Each member of the trial team must demonstrate that they have been properly trained on the protocol, investigational product (IP), sponsor SOPs, safety procedures, and applicable regulations. This training must be documented in a clear, structured, and audit-ready format.

Sponsors, CROs, and inspectors from regulatory authorities like the FDA or EMA routinely verify training logs and attendance records. The use of standardized templates ensures that all necessary data points are captured consistently and that documentation is easy to locate in the Investigator Site File (ISF) or Trial Master File (TMF).

This article outlines the key templates required for training documentation and provides detailed guidance on their structure, purpose, and regulatory value.

Key Regulatory Expectations: GCP and Training Records

Regulatory authorities require training documentation to be:

• Attributable: Each entry should clearly show who was trained, when, and by whom
• Complete: All training activities, including protocol updates and safety briefings, must be documented
• Verifiable: Training logs should align with delegation logs and CRA reports
• Version-Controlled: Each training should reference the correct version of the materials used
• Contemporaneous: Records must be filled in at the time of training, not retrospectively

ICH E6(R2) specifically mandates that each person involved in a trial be qualified by education, training, and experience (Section 2.8), and that these qualifications be documented (Sections 8.2.29 and 8.3.20).

Template 1: Master Training Log Format

The master training log provides a centralized view of all training activities conducted at a site. It should include:

This log must be filed under the “Training” section of the ISF and checked during monitoring visits. Sites using a Learning Management System (LMS) may generate system logs, but a paper version is often maintained for backup and on-site access.

Template 2: Training Attendance Sheet

For group training sessions, a separate attendance sheet is useful. This sheet typically includes:

• Date of Training
• <strongTraining Topic and Version
• Location (Onsite/Remote)
• Facilitator Name
• Names of Attendees
• Signatures of Attendees

Below is a sample layout:

Internal Link

For downloadable templates and editable formats, visit PharmaSOP.in or explore training checklist repositories on PharmaValidation.in.

Template 3: Retraining Log

Retraining is often required due to protocol amendments, deviations, or staff role changes. A dedicated retraining log helps document these instances clearly. Key columns include:

This log ensures that updates are traceable and aligned with the appropriate protocol or SOP version. The form should be cross-referenced with the protocol amendment history in the ISF.

Template 4: CRA Training Verification Form

Sponsors expect CRAs to verify that training records exist, are up to date, and correspond to delegated roles. The CRA verification form should include:

• Confirmation that training was conducted before delegation
• Version of training materials used
• Checklist of attendees vs delegation log entries
• Date of CRA review and initials

CRA verification forms are often filed with visit reports or appended to monitoring checklists. This adds a second level of quality assurance for sponsors and auditors.

Template 5: Electronic LMS Export Format

If a Learning Management System (LMS) is used, the exported training record must:

• Display user login name and full name
• Include time-stamped completion date and version
• Be locked or signed electronically (per 21 CFR Part 11)
• Include audit trail of completion events
• Be retained as a PDF in the ISF or TMF

A common inspection finding is incomplete or outdated LMS exports that do not align with protocol versioning. SOPs should define how and when these reports are generated and filed.

Template 6: GCP Certificate Archive Log

Many sponsors require evidence that all clinical staff completed GCP training. This template can track:

• Staff Name and Role
• Date of Completion
• Training Provider
• Expiry Date (usually 2–3 years)
• Location of certificate (digital or paper)

A central archive log allows the CRA and auditor to confirm GCP training across all team members. Certificates may also be linked to the staff CV in the ISF.

External Link and Inspection Readiness

Refer to FDA’s Bioresearch Monitoring Compliance Program Manual for specific expectations on documentation. EMA inspectors also evaluate whether templates and training logs are traceable, accurate, and consistently completed across sites.

Conclusion: Templates as Risk Mitigation Tools

Standardized templates are not just administrative tools—they are central to risk mitigation and inspection readiness in clinical research. From tracking protocol-specific training to verifying CRA reviews and GCP compliance, each form plays a vital role in documenting that staff are fit for duty.

Sites should store blank and completed templates in the ISF, ensure version control, and update SOPs to reflect usage. When combined with proper oversight, these tools enhance transparency, compliance, and trial quality.

For a downloadable SOP-template pack and sponsor-approved log formats, visit PharmaSOP.in or training documentation examples at PharmaValidation.in.